Resources about inherited cancer risk for healthcare providers
Approximately 5-10% of all cancer is due to hereditary cancer syndromes. More cancers are likely influenced by genetic factors associated with moderate risk. Being able to identify individuals at increased cancer risk through family history and, in some cases, genetic testing, can influence management and outcomes through increasing screening and/or risk-reducing interventions. The resources below provide opportunities to learn about hereditary cancer syndromes, identify individuals at increased risk, interpret genetic testing results, apply genetic information to management, collaborate with genetics professionals, and communicate with patients.
Free, self-directed programs for continuing education credit.
Cancer Genetic Clinical Education Program
Build skills to identify and manage patients who at increased risk of cancer based on family health history and/or genetic testing. Choose from 11 short, case-based modules.
Hereditary Cancer Syndromes: Are Your Patients at Risk?
Develop skills and knowledge to identify patients with cancer who are most appropriate for germline testing, choose the right test, and using the results to develop a management plan.
Access CME Module
These factsheets describe the clinical features, diagnosis, testing, and genetics of the following hereditary cancer syndromes.
Family History Collection Tips & Tools. Provides tips, resources, and tools for family history collection in clinical practice.
Cancer Genetic Risk Assessment. Helps identify red flags and stratify cancer risk based on family history.
Genetically Related Cancers. Provides key features and cancer risks associated with common hereditary cancer syndromes.
Risk Assessment and Screening Toolkit to Detect Familial, Hereditary, and Early Onset Colorectal Cancer. Helps primary care providers implement a structured family history collection system to identify and manage individuals at increased or high risk of colorectal cancer (CRC), and to facilitate timely diagnostic evaluation of patients with signs or symptoms of early onset CRC.
Comparing Genetic Tests. Provides a quick reference for the detection capabilities for common types of genetic testing, such as gene sequencing and deletion/duplication analysis.
Hereditary Cancer Panels. Provides considerations when evaluating different multi-gene panels for hereditary cancer testing.
Genetic Testing Methods eBook. Provides information about different genetic testing methods currently used in testing for hereditary cancer syndromes.
Genetic Testing Results Interpretation Tool. Outlines how to interpret results from cancer genetic testing in different patient situations.
Cancer Screening. Summarizes professional society guidance about screening for individuals at average, increased, and high risk for breast, prostate, and colorectal cancer.
Patient Management after Genomic Testing. Summarizes patient care and management steps for patients with positive, negative, uncertain, and unexpected results from genomic testing.
Hereditary Cancer Management Guidelines. Provides access to current management guidelines based on genetic or familial risk.
Communicating Genetic Risk. Outlines key points to consider when communicating risk to patients.
Pretest Counseling Recommendations. Outlines key points to address during pretest counseling.
Informed Consents and Pretest Counseling Checklist. Provides a checklist of key points to cover with patients prior to genetic testing.
Communicating with Family. Outlines key points to consider when discussing family communication with patients.
Components of a Cancer Genetic Counseling Session. Discusses the core components of a cancer genetic counseling session.
Accessing Genetic Services. Lists tools and websites to help find genetics professionals and provides patient talking points about referring to genetics. Find cancer genetic services in ME, CT, and Western NY.
Hereditary Breast Cancer Patient and Family Resources. Provides patient resources for understanding genetic services and breast cancer genetics.
Beyond Genetics: Genomics in Breast Cancer Diagnosis, Treatment, and Research. Explores one cancer survivor’s journey through diagnosis, treatment, and life after treatment.
What are telomeres and what are their purpose in our bodies? In this Minute to Understanding, we give you all the basic information about...
Jens Rueter, M.D. has been appointed the first ever chief medical officer of The Jackson Laboratory. Rueter is a practicing...
Dan Durkin, technical team lead on the Clinical Knowledgebase (CKB), gives a first hand explanation of this powerful tool (available to...
Gliomas, malignant brain tumors, are considered incurable by current science. What, then, makes them so adaptable and...
NCI Pediatric PIVOT program, run by JAX, aims to expedite approval of treatments for childhood cancers.
With November designated as Family Health History month, clinicians are sure to have seen lots of messaging encouraging their patients to...
What is a mouse model? Find out in this Minute to Understanding from the Jackson Laboratory!
The Cancer Short Course provides a broad survey of the cancer research and experimental modeling from systems and computational genetics,...
Primarily works on patient-derived xenografts (PDX) and genetically engineered mouse models (GEMM) projects
Pluripotent Germ Cells factor, Pediatric Germ Cell tumor biology, preclinical drug screening. Pediatric AML tumors.
A lifelong friendship inspires support for JAX blood cancer research.
Developing and deploying novel NGS/Third generation (Oxford Nanopore/Pacific Bioscience) assays to benefit the commercial objective of the...
Donna is a 60-year-old Black woman with a personal history of breast cancer, diagnosed at age 49. Her oncologist recommended she consider...
Jennifer Trowbridge of JAX seeks to thwart the mutations and inflammation that accumulate in aging bone marrow to maintain...
My primary research focus is Hematological malignancies. I am primarily looking into aging and cancer using cutting edge technologies like...
Development of novel computational, statistical and mathematical approaches for the analysis of Next Generation Sequencing...
Allow essential cookies
Required for basic site operations.
Allow analytics cookies
Used to analyze web traffic to improve the user experience.
Allow marketing cookies
Used to deliver personalized information and tailor communications.